Search
Thursday 21 January 2016
  • :
  • :

Active Stocks News Review: Morgan Stanley (NYSE:MS), Meritor (NYSE:MTOR), DexCom (NASDAQ:DXCM)

On Thursday, Morgan Stanley (NYSE:MS)’s shares declined -1.33% to $31.80. With its recent share price change, MS market value has reached roughly $61.59 billion. The company has a Profit Margin (ttm) of 8.30% and has 86.90% gross margins. The operating profit margin is 10.80%. The stock’s performance in 1 month is -9.81% and its volatility for the same period is 1.27%.

Morgan Stanley (NYSE:MS) has lost 2.06% during the past week and dropped 9.94% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 1.25%. Morgan Stanley (NYSE:MS) has underperformed the index by 7.83% in the last 4 weeks. Investors should watch out for further signals and trade with caution.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide. The company’s Institutional Securities segment offers financial advisory services on mergers and acquisitions, divestitures, joint ventures, corporate restructurings, recapitalizations, spin-offs, exchange offers, leveraged buyouts, takeover defenses, and shareholder relations, in addition to provides capital raising and corporate lending services.

Meritor Inc (NYSE:MTOR)’s shares gained 0.36% to $8.35. The market capitalization of Meritor Inc (NYSE:MTOR) is $762.60 Million with the total traded volume of the company is 1.08 million. Turning to market valuation, the Price-to-Earnings ratio is 13.47; the Price-to-Sales ratio is 0.22. The beta ratio has a value of 2.63.

Shares of Meritor, Inc. (NYSE:MTOR) appreciated by 0.12% during the past week but lost 11.55% on a 4-week basis. The shares have outperformed the S&P 500 by 0.96% in the past week but underperformed the index by 9.48% in the last 4 weeks.

Meritor, Inc. designs, develops, manufactures, markets, distributes, sells, services, and supports integrated systems, modules, and components to original equipment manufacturers (OEMs) and the aftermarket for the commercial vehicle, transportation, and industrial sectors worldwide. It operates through two segments, Commercial Truck & Industrial; and Aftermarket & Trailer.

DexCom, Inc. (NASDAQ:DXCM)‘s shares dipped -0.55% to $81.90. The last trading range of DexCom, Inc. (NASDAQ:DXCM) ranges between $81.40 and $83.03. The EPS of the company stands at $-0.72. The 52-week range shows that the stock reached higher at $103.29 while its lower range is $53.30 in the last 52-weeks. The average volume of the company is at 529,755.00 with the Outstanding Shares of 81.29 million. The market capitalization of the company is $6.66 billion. The Beta of the company stands at 0.36 with the RSI (Relative Strength Index) of 43.90.

Shares of DexCom, Inc. (NASDAQ:DXCM) appreciated by 0.95% during the past week but lost 6.69% on a 4-week basis. The shares have outperformed the S&P 500 by 1.79% in the past week but underperformed the index by 4.51% in the last 4 weeks.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes.




Leave a Reply

Your email address will not be published. Required fields are marked *